Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study

To investigate the association between glucocorticoid-induced osteoporosis and myasthenia gravis (MG) using a cross-sectional survey in Japan. We studied 363 patients with MG (female 68%; mean age, 57 ± 16 years) who were followed at six Japanese centers between April and July 2012. We evaluated the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2015-05, Vol.10 (5), p.e0126579-e0126579
Hauptverfasser:	Konno, Shingo, Suzuki, Shigeaki, Masuda, Masayuki, Nagane, Yuriko, Tsuda, Emiko, Murai, Hiroyuki, Imai, Tomihiro, Fujioka, Toshiki, Suzuki, Norihiro, Utsugisawa, Kimiaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of daily living Adult Aged Analysis Biocompatibility Bone Density Bone mineral density Complications and side effects Cross-sectional studies Dosage and administration Drug dosages Ethics Female Fractures Fractures, Bone - chemically induced Fractures, Bone - epidemiology Fractures, Bone - physiopathology Glucocorticoids Glucocorticoids - adverse effects Hospitals Humans Laboratories Lupus Male Middle Aged Myasthenia Myasthenia gravis Myasthenia Gravis - chemically induced Myasthenia Gravis - epidemiology Myasthenia Gravis - physiopathology Neurology Neuromuscular junctions Osteoporosis Osteoporosis - chemically induced Osteoporosis - epidemiology Osteoporosis - physiopathology Patients Prednisolone Quality assessment Quality of Life Rheumatoid arthritis Risk factors Studies Surveys
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!